Edesa Biotech, Inc.
General ticker "EDSA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $10.8M (TTM average)
Edesa Biotech, Inc. does not follow the US Stock Market performance with the rate: -9.9%.
Estimated limits based on current volatility of 2.2%: low 1.41$, high 1.48$
Factors to consider:
- Total employees count: 16 as of 2023
- Top business risk factors: Inability to raise capital, Regulatory and compliance, No commercial products, Operating losses, Labor/talent shortage/retention
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [1.50$, 4.26$]
- 2026-09-30 to 2027-09-30 estimated range: [1.09$, 3.20$]
Financial Metrics affecting the EDSA estimates:
- Positive: with PPE of -1.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -53.06 <= 0.04
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 91.15 > 64.17
- Positive: Investing cash flow per share per price, % of 0 > -0.62
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
Short-term EDSA quotes
Long-term EDSA plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $9.22MM | $7.01MM | $7.91MM |
| Operating Income | $-9.22MM | $-7.01MM | $-7.91MM |
| Non-Operating Income | $0.85MM | $0.85MM | $0.73MM |
| R&D Expense | $4.79MM | $2.88MM | $3.67MM |
| Income(Loss) | $-8.37MM | $-6.17MM | $-7.18MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-8.37MM | $-6.17MM | $-7.19MM |
| Stockholders Equity | $7.05MM | $1.98MM | $12.45MM |
| Assets | $8.89MM | $3.81MM | $13.66MM |
| Operating Cash Flow | $-6.64MM | $-4.89MM | $-7.32MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-0.03MM | $0.00MM |
| Financing Cash Flow | $4.83MM | $0.59MM | $17.03MM |
| Earnings Per Share** | $-2.93 | $-1.93 | $-1.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.